Analysis of multiplex endogenous estrogen metabolites in human urine using ultra-fast liquid chromatography-tandem mass spectrometry: A case study for breast cancer

Analytica Chimica Acta

Volumn 711, Issue , 2012, Pages 60-68

  Huang, Jiang ^a   Sun, Jianghao ^a   Chen, Yanhua ^a   Song, Yongmei ^b   Dong, Lijia ^b   Zhan, Qinmin ^b   Zhang, Ruiping ^a   Abliz, Zeper ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b CANCER HOSPITAL   (China)

Author keywords

Breast cancer; Estrogen metabolite; Metabolic profiling; Ultra fast liquid chromatography tandem mass spectrometry; Urine

Indexed keywords

ACCURACY AND PRECISION; ACCURATE ANALYTICAL METHODS; ANALYTES; BREAST CANCER; BREAST CANCER RISK; CARCINOGENIC MECHANISM; FEMALE BREAST; HEALTHY CONTROLS; HUMAN URINE; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LOWER LIMIT OF QUANTITATIONS; METABOLIC PATHWAYS; METABOLIC PROFILING; PROTECTIVE EFFECTS; QUANTITATIVE METHOD; TANDEM MASS SPECTROMETRY; TUMOR FORMATION; ULTRA-FAST; ULTRA-FAST LIQUID CHROMATOGRAPHY; ULTRA-FAST LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; URINE; URINE SAMPLE; VALIDATED METHODS;

BIOMOLECULES; BODY FLUIDS; CHROMATOGRAPHY; DISEASES; HIGH PRESSURE LIQUID CHROMATOGRAPHY; HYDROXYLATION; LIQUIDS; MASS SPECTROMETRY; METABOLITES; PHENOLS;

METABOLISM;

16 OXOESTRADIOL; 16ALPHA HYDROXYESTRONE; 17 EPIESTRIOL; 2 HYDROXYESTRADIOL; 2 HYDROXYESTRONE 3 METHYL ETHER; 2 METHOXYESTRADIOL; 2 METHOXYESTRONE; 4 HYDROXYESTRADIOL; 4 METHOXYESTRADIOL; 4 METHOXYESTRONE; BIOLOGICAL MARKER; CATECHOL ESTROGEN; DNA; EPIESTRIOL; ESTRADIOL; ESTRIOL; ESTROGEN; ESTRONE; QUINONE DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CONTROLLED STUDY; DERIVATIZATION; ESTROGEN METABOLISM; EXTRACTION; FEMALE; HUMAN; HYDROLYSIS; HYDROXYLATION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; METABOLITE; MUTATION; POSTMENOPAUSE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; TANDEM MASS SPECTROMETRY; ULTRA FAST LIQUID CHROMATOGRAPHY; URINALYSIS;

BREAST NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESTROGENS; FEMALE; HUMANS; LIMIT OF DETECTION; MIDDLE AGED; MOLECULAR STRUCTURE; REFERENCE STANDARDS; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 83055176263     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2011.10.058     Document Type: Article

References (51)

1. Clemons M., Goss P. N. Engl. J. Med. 2001, 344:276-285.
2. Beatson G. Lancet 1896, 11:104-107.
3. Parl F.F., Dawling S., Roodi N., Crooke P.S. Ann. N. Y. Acad. Sci. 2009, 1155:68-75.
4. Yager J.D. J. Natl. Cancer Inst. 2000, 27:67-73.
5. Ethier S.P. J. Natl. Cancer Inst. 1995, 87:964-973.
6. Feigelson H.S., Henderson B.E. Carcinogenesis 1996, 17:2279-2284.
7. Cavalieri E.L., Stack D.E., Devanesan P.D., Todorovic R., Dwivedy I., Higginbotham S. Proc. Natl. Acad. Sci. 1997, 94:10937-10942.
8. Cavalieri E., Charkravarti D., Guttenplan J., Hart E., Ingle J., Janhowiak R., Muti P., Rogan E., Russo J., Santen R., Sutter T. Biochim. Biophys. Acta 2006, 1766:63-78.
9. Yue W., Santen R.J., Wang J.P., Li Y., Verderame M.F. J. Steroid Biochem. Mol. Biol. 2003, 86:477-486.
10. Rogan E.G., Cavalieri E.L. Adv. Clin. Chem. 2004, 38:135-149.
11. Rogan E.G., Badawi A.F., Devanesan P.D., Meza J.L., Edney J.A., West W.W., Higginbotham S.M., Cavalieri E.L. Carcinogenesis 2003, 24:697-702.
12. Mueck A.O., Seeger H. Muturitas 2007, 57:42-46.
13. Ursin G., London S., Stanczyk F.Z., Gentzschein E., Paganini-Hill A., Ross R.K., Pike M.C. J. Natl. Cancer Inst. 1999, 91:1067-1072.
14. Meilahn E.N., de Stavola B., Allen D.S., Fentiman I., Bradlow H.L., Sepkovic D.W., Kuller L.H. Br. J. Cancer 1998, 78:1250-1255.
15. Lemon H.M., Heidel J.W., Rodriguez-Sierra J. Cancer (Phila.) 1992, 69:457-465.
16. Schutze N., Vollmer G., Tiemann I. J. Steroid Biochem. Mol. Biol. 1993, 46:781-789.
17. Cauley J.A., Zmuda J.M., Danielson M.E., Ljung B.M., Bauer D.C., Cummings S.R., Kuller L.H. Epidemiology 2003, 14:740-744.
18. Adlercreutz H., Gorbach S.L., Goldin B.R., Woods M.N., Dwyer J.T., Hamalainen E. J. Natl. Cancer Inst. 1994, 86:1076-1082.
19. Kabat G.C., Chang C.J., Sparano J.A., Sepkovic D.W., Hu X.P., Khalil A., Rosenblatt R., Bradlow L. Cancer Epidemiol. Biomarkers Prev. 1997, 6:505-509.
20. Bradlow H.L., Telang N.T., Sepkovic D.W., Osborne M.P. J. Endocrinol. 1996, 150:259-265.
21. Ball P., Reu G., Schwab J., Knuppen R. Steroids 1979, 33:563-576.
22. Emons G., Mente C., Knuppen R., Ball P. Acta Endocrinol. (Copenh) 1981, 97:251-257.
23. Ziegler R.G., Rossi S.C., Fears T.R., Bradlow H.L., Adlercreutz H., et al. Environ. Health Perspect. 1997, 105:607-614.
24. Fowke J.H., Qi D., Bradlow H.L., Shu X.O., Gao Y.T., Cheng J.R. Steroids 2003, 68:65-72.
25. Suzuki E., Saegusa K., Matsuki Y., Nambara T. J. Chromatogr. 1993, 617:221-225.
26. Yamada H., Yoshizawa K., Hayase T. J. Chromatogr. B 2002, 775:209-213.
27. Adlercreutz H., Kiuru P., Rasku S., Wahala K., Fotsis T. J. Steroid Biochem. Mol. Biol. 2004, 92:399-411.
28. Stopforth A., Burger B.V., Crouch A.M., Sandra P. J. Chromatogr. B 2007, 856:156-164.
29. Xu X., Keefer L.K., Ziegler R.G., Veenstra T.D. Nat. Protoc. 2007, 6:1350-1355.
30. Xu X., Veenstra T.D., Fox S.D., Roman J.M., Issaq H.J., Falk R., Saavedra J.E., Keefer L.K., Ziegler R.G. Anal. Chem. 2005, 77:6646-6654.
31. Xu X., Roman J.M., Issaq H.J., Keefer L.K., Veenstra T.D., Ziegler R.G. Anal. Chem. 2007, 79:7813-7821.
32. Guo T.G., Gu J.H., Soldin O.P., Singh R.J., Soldin S.J. J. Clin. Biochem. 2008, 41:736-741.
33. Lakhani N.J., Lepper E.R., Sparreboom A., Dahut W.L. Rapid Commun. Mass Spectrom. 2005, 19:1176-1182.
34. Qin F., Zhao Y.Y., Sawyer M.B., Li X.F. Anal. Chem. 2008, 80:3404-3411.
35. Zhang H.W., Henion J. Anal. Chem. 1999, 71:3955-3964.
36. Huang H.J., Chiang P.H., Chen S.H. J. Chromatogr. B 2011, 879:1748-1756.
37. Farré M., Kuster M., Brix R., Rubio F., López de Alda M.J., Braceló D. J. Chromatogr. A 2007, 1160:166-175.
38. Chen Y.H., Zhang R.P., Song Y.M., He J.M., Sun J.H., Bai J.F., An Z.L., Dong L.J., Zhan Q.M., Abliz Z. Analyst 2009, 134:2003-2011.
39. An Z.L., Chen Y.H., Zhan R.P., Song Y.M., Sun J.H., He J.M., Bai J.F., Dong L.J., Zhan Q.M., Abliz Z. J. Proteome Res. 2010, 9:4071-4081.
40. Qin F., Zhao Y.Y., Sawyer M.B., Li X.F. Anal. Chim. Acta 2008, 627:91-98.
41. Xia Y.Q., Chang S.W., Patel S., Bakhtiar R., Karanam B., Evans D.C. Rapid Commun. Mass Spectrom. 2004, 18:1621-1628.
42. Westerlind K.C., Gibson K.J., Wolfe P. Steroids 1999, 64:233-243.
43. Santen R.J., Leszczynski D., Tilson-Mallet N., et al. Ann. N. Y. Acad. Sci. 1986, 464:126-137.
44. Obi N., Vrieling A., Heinz J., Chang-Claude J. Int. J. Womens Health 2011, 3:37-51.
45. Taiolo E., Im A., Xu X., Veenstra T.D., Gretchen A. Reprod. Biol. Endocrinol. 2010, 8:93-99.
46. Guidance for Industry-bioanalytical method validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), Rockville, MD, USA. , 2001 (accessed 31.01.11). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf.
47. Seeger H., Huober J., Wallwiener D., Mueck A.O. Horm. Metab. Res. 2004, 36:277-280.
48. Sepkovic D.W., Bradlow H.L. Ann. N. Y. Acad. Sci. 2009, 1155:57-67.
49. Todorovic R., Devanesan P., Higginbotham S., Zhao J. Carcinogenesis 2001, 22:905-911.
50. Zhu B.T. Curr. Drug Metab. 2003, 3:321-349.
51. Lakhani N.J., Sarkar M.A., Venitz J., Figg W.D. Pharmacotherapy 2003, 23:165-172.